BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

508 related articles for article (PubMed ID: 31318428)

  • 1. Development and validation of a multivariable prediction model for major adverse cardiovascular events after early stage breast cancer: a population-based cohort study.
    Abdel-Qadir H; Thavendiranathan P; Austin PC; Lee DS; Amir E; Tu JV; Fung K; Anderson GM
    Eur Heart J; 2019 Dec; 40(48):3913-3920. PubMed ID: 31318428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and Validation of the Chronic Disease Population Risk Tool (CDPoRT) to Predict Incidence of Adult Chronic Disease.
    Ng R; Sutradhar R; Kornas K; Wodchis WP; Sarkar J; Fransoo R; Rosella LC
    JAMA Netw Open; 2020 Jun; 3(6):e204669. PubMed ID: 32496565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A clinical decision instrument to predict 30-day death and cardiovascular hospitalizations after an emergency department visit for atrial fibrillation: The Atrial Fibrillation in the Emergency Room, Part 2 (AFTER2) study.
    Atzema CL; Dorian P; Fang J; Tu JV; Lee DS; Chong AS; Austin PC
    Am Heart J; 2018 Sep; 203():85-92. PubMed ID: 30053692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Risk of Heart Failure and Other Cardiovascular Hospitalizations After Early Stage Breast Cancer: A Matched Cohort Study.
    Abdel-Qadir H; Thavendiranathan P; Austin PC; Lee DS; Amir E; Tu JV; Fung K; Anderson GM
    J Natl Cancer Inst; 2019 Aug; 111(8):854-862. PubMed ID: 30715404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of predictive risk models for major adverse cardiovascular events among patients with type 2 diabetes mellitus using health insurance claims data.
    Young JB; Gauthier-Loiselle M; Bailey RA; Manceur AM; Lefebvre P; Greenberg M; Lafeuille MH; Duh MS; Bookhart B; Wysham CH
    Cardiovasc Diabetol; 2018 Aug; 17(1):118. PubMed ID: 30143045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. International Validation of the Thrombolysis in Myocardial Infarction (TIMI) Risk Score for Secondary Prevention in Post-MI Patients: A Collaborative Analysis of the Chronic Kidney Disease Prognosis Consortium and the Risk Validation Scientific Committee.
    Mok Y; Ballew SH; Bash LD; Bhatt DL; Boden WE; Bonaca MP; Carrero JJ; Coresh J; D'Agostino RB; Elley CR; Fowkes FGR; Jee SH; Kovesdy CP; Mahaffey KW; Nadkarni G; Peterson ED; Sang Y; Matsushita K
    J Am Heart Assoc; 2018 Jul; 7(14):. PubMed ID: 29982232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular and Renal Morbidity in Takayasu Arteritis: A Population-Based Retrospective Cohort Study From the United Kingdom.
    Goel R; Chandan JS; Thayakaran R; Adderley NJ; Nirantharakumar K; Harper L
    Arthritis Rheumatol; 2021 Mar; 73(3):504-511. PubMed ID: 32969145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and Validation of a Risk Score Model for Predicting the Cardiovascular Outcomes After Breast Cancer Therapy: The CHEMO-RADIAT Score.
    Kim DY; Park MS; Youn JC; Lee S; Choi JH; Jung MH; Kim LS; Kim SH; Han S; Ryu KH
    J Am Heart Assoc; 2021 Aug; 10(16):e021931. PubMed ID: 34369199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of Considering Competing Risks in Time-to-Event Analyses: Application to Stroke Risk in a Retrospective Cohort Study of Elderly Patients With Atrial Fibrillation.
    Abdel-Qadir H; Fang J; Lee DS; Tu JV; Amir E; Austin PC; Anderson GM
    Circ Cardiovasc Qual Outcomes; 2018 Jul; 11(7):e004580. PubMed ID: 29997149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Novel Model for Prediction of Thromboembolic and Cardiovascular Events in Patients Without Atrial Fibrillation.
    Steensig K; Olesen KKW; Madsen M; Thim T; Jensen LO; Würtz M; Kristensen SD; Bøtker HE; Lip GYH; Eikelboom JW; Maeng M
    Am J Cardiol; 2020 Sep; 131():40-48. PubMed ID: 32718550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Population-Based Study of Cardiovascular Mortality Following Early-Stage Breast Cancer.
    Abdel-Qadir H; Austin PC; Lee DS; Amir E; Tu JV; Thavendiranathan P; Fung K; Anderson GM
    JAMA Cardiol; 2017 Jan; 2(1):88-93. PubMed ID: 27732702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Essen stroke risk score predicts recurrent cardiovascular events: a validation within the REduction of Atherothrombosis for Continued Health (REACH) registry.
    Weimar C; Diener HC; Alberts MJ; Steg PG; Bhatt DL; Wilson PW; Mas JL; Röther J;
    Stroke; 2009 Feb; 40(2):350-4. PubMed ID: 19023098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The risk trajectory of different cardiovascular morbidities associated with chronic kidney disease among patients with newly diagnosed diabetes mellitus: a propensity score-matched cohort analysis.
    Chao CT; Lee SY; Wang J; Chien KL; Hung KY
    Cardiovasc Diabetol; 2021 Apr; 20(1):86. PubMed ID: 33894776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of cardiovascular events and mortality among a population-based cohort of immigrants and long-term residents with diabetes: Are all immigrants healthier and if so, for how long?
    Okrainec K; Bell CM; Hollands S; Booth GL
    Am Heart J; 2015 Jul; 170(1):123-32. PubMed ID: 26093873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk Prediction Tools to Improve Patient Selection for Carotid Endarterectomy Among Patients With Asymptomatic Carotid Stenosis.
    Keyhani S; Madden E; Cheng EM; Bravata DM; Halm E; Austin PC; Ghasemiesfe M; Abraham AS; Zhang AJ; Johanning JM
    JAMA Surg; 2019 Apr; 154(4):336-344. PubMed ID: 30624562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical prediction rule to estimate the absolute 3-year risk of major cardiovascular events after carotid endarterectomy.
    van Lammeren GW; Catanzariti LM; Peelen LM; de Vries JP; de Kleijn DP; Moll FL; Pasterkamp G; Bots ML
    Stroke; 2012 May; 43(5):1273-8. PubMed ID: 22442175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison between angiotensin converting enzyme inhibitors and angiotensin receptor blockers on end stage renal disease and major adverse cardiovascular events in diabetic patients: a population-based dynamic cohort study in Taiwan.
    Wu LS; Chang SH; Chang GJ; Liu JR; Chan YH; Lee HF; Wen MS; Chen WJ; Yeh YH; Kuo CT; See LC
    Cardiovasc Diabetol; 2016 Apr; 15():56. PubMed ID: 27039185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular Disease in Patients With Breast Cancer Treated in the Modern Era.
    Murphy AC; Koshy AN; Farouque O; Yeo B; Roccisano L; Octavia Y; Yudi MB
    Heart Lung Circ; 2024 May; 33(5):648-656. PubMed ID: 37574416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and Validation of a Prognostic Survival Model With Patient-Reported Outcomes for Patients With Cancer.
    Seow H; Tanuseputro P; Barbera L; Earle C; Guthrie D; Isenberg S; Juergens R; Myers J; Brouwers M; Sutradhar R
    JAMA Netw Open; 2020 Apr; 3(4):e201768. PubMed ID: 32236529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of chronic obstructive pulmonary disease on prognosis in atrial fibrillation: A report from the EURObservational Research Programme Pilot Survey on Atrial Fibrillation (EORP-AF) General Registry.
    Proietti M; Laroche C; Drozd M; Vijgen J; Cozma DC; Drozdz J; Maggioni AP; Boriani G; Lip GY;
    Am Heart J; 2016 Nov; 181():83-91. PubMed ID: 27823697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.